| EX1509 MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR B- ALL |
| Specimen: |
3 mL (1 mL min.) First, pull Bone Marrow aspirate in 1 Green Top (Sodium Heparin) tube. Ship immediately at 18-22°C. DO NOT FREEZE. 2 mL Bone Marrow EDTA for Metropolis. |
| Stability: |
| Room |
Refrigerated |
Frozen |
| 24 hrs at 18-22°C |
NA |
NA |
|
| Method: |
Flow Cytometry |
| Comment: |
|
| Report: |
Contact us to know the TAT. |
| Usage: |
Detection of Minimal Residual Disease (MRD) in Acute lymphoblastic leukemia predicts outcome. This assay can identify patients at higher/lower risk of relapse. Detection of MRD is important for risk assessment and stratification of therapy. |
| Doctor Specialty: |
Oncologist |
| Disease: |
Leukemia |
| Components: |
*CD10 *CD13 *CD15 *CD19 *CD20 *CD33 *CD34 *CD38 *CD45 *CD58 *CD73 *CD86 *CD123 *CD200 *SYTO-16 |
| Courier Charges: |
0.00 |
| Home Collection: |
Available (*T&C Apply) |
| Department: |
FLOW CYTOMETRY |
| Pre Test Information: |
It is mandatory to provide the Date & Time of sampling, Previous immunophenotype report & Clinical history. |
Reviews
There are no reviews yet.